Euglycemic diabetic ketoacidosis following major vascular surgery is a new item on the differential for postoperative acidosis

New pharmacologic advances in the treatment of diabetes include SGLT-2 inhibitors, which have been demonstrated in randomized-controlled clinical trials to reduce overall and cardiac-specific mortality and slow progression of chronic kidney disease. Euglycemic diabetic ketoacidosis is a rare but lif...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Clara M. Gomez-Sanchez, MD, Bian X. Wu, MD, Jeffrey E. Gotts, MD, Robert W. Chang, MD
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Accès en ligne:https://doaj.org/article/3006de9df1f84acda593c0de6bbb7600
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!